Skip to content
CSE: XRX.CN 0.14 0.00 0.00%  
XORTX
  • About
    • Management Team
    • Board of Directors
    • Advisory Board
  • Pipeline
    • Autosomal Dominant Polycystic Kidney Disease
    • Diabetic Nephropathy
    • Metabolic Syndrome / Diabetes
    • Hypertension
  • Strategic Partnerships
  • Investors
    • Press Releases
    • Presentations
    • Media
    • Financials
    • SEDAR
    • Transfer Agent
    • Upcoming Events
  • Contact
Site Search

callout-three

callout-three

Leave a Reply Cancel reply

Your email address will not be published.

Press Releases

  • XORTX Announces Virtual Investor Conference Live Webcast July 30, 2019
  • XORTX Reports Annual & Special Meeting Results July 18, 2019
  • XORTX Shares Nature Nephrology Review July 15, 2019
  • XORTX Provides Overview and Announces $5 Million Financing to Advance Clinical Trials April 29, 2019
  • XORTX Shares Findings of Diabetes Study in Youths Supporting High Uric Acid Advances Kidney Disease Progression April 16, 2019
XORTX Therapeutics Inc.
4000, 421 7th Avenue SW
Calgary, Alberta T2P 4K9
Ph: +1 (403) 455-7727
info@xortx.com
Theme by Colorlib Powered by WordPress